
Bioorganic and Medicinal Chemistry Letters p. 881 - 886 (1997)
Update date:2022-08-04
Topics:
Peglion, Jean-Louis
Vian, Joel
Goument, Bertrand
Despaux, Nicole
Audinot, Valerie
Millan, Mark J.
Starting from the structure of the preferential D3 antagonist S 14297 (1), we have prepared a series of cis and trans tetracyclic derivatives of general formula I in order to improve potency and selectivity for D3 receptors. The trans oxazino derivative 2c, showed slightly increased affinity at D3 receptors and double the selectivity for D3 over D2 receptors, in comparison to S 14297. Cis derivatives and compounds where R1 is aralkyl were totally devoid of activity.
View Morewebsite:http://www.lonwinchem.com
Contact:Tel: 86-21-59858395
Address:No#966,Huaxu Road,Shanghai 201702,P.R.China
Nanjing Vincero International Trading Co.,Ltd
Contact:8618936897229
Address:NO.68, ZhuShan Road, JiangNing WanDa Plaza, Building E Room 1703
Contact:86-931-8272767
Address:Room 602, No.461, Nanchang Road, Chengguan District, Lanzhou City, China PRC
Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd
Contact:+86-517-86283327
Address:9 North Hantai Road, Huaian, China
Shanghai Gsyn Chemical Co.,Ltd.
Contact:86-021-67158290
Address:86-021-67158291
Doi:10.1016/S0014-827X(99)00017-8
(1999)Doi:10.1016/j.poly.2010.12.049
(2011)Doi:10.1016/j.tetlet.2008.03.138
(2008)Doi:10.1039/DT9900002321
(1990)Doi:10.1002/ardp.200400884
(2004)Doi:10.1016/j.bmcl.2011.02.058
(2011)